(Q48473146)

11 February 2018

title

The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study (English)

1 reference

11 February 2018

author name string

Jinying Zhang

1

1 reference

11 February 2018

Lingjun Zhu

2

1 reference

11 February 2018

Juan Wei

3

1 reference

11 February 2018

Lingxiang Liu

4

1 reference

11 February 2018

Yongmei Yin

5

1 reference

11 February 2018

Yanhong Gu

6

1 reference

11 February 2018

Yongqian Shu

7

1 reference

11 February 2018

publication date

4 March 2012

1 reference

11 February 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

11 February 2018

volume

138

1 reference

11 February 2018

issue

6

1 reference

11 February 2018

page(s)

1057-1062

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s00432-012-1179-1

exact match

0 references

cites work

Triptolide induced cytotoxic effects on human promyelocytic leukemia, T cell lymphoma and human hepatocellular carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1179-1

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1179-1

Inhibition of human ovarian tumor growth by cytokine-induced killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1179-1

A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1179-1

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1179-1

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1179-1

Studies on inducing apoptosis effects and mechanism of CIK cells for MGC-803 gastric cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1179-1

Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1179-1

Recognition of breast cancer cells by CD8+ cytotoxic T-cell clones specific for NY-BR-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1179-1

Generation of cytokine-induced killer cells using exogenous interleukin-2, -7 or -12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1179-1

Lymphocyte subsets, lymphocyte reactivity to mitogens, NK cell activity and neutrophil and monocyte phagocytic functions in patients with bladder carcinoma.

21 January 2018

1 reference

12 December 2020

Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells.

1 reference

12 December 2020

The proliferation profile in vitro and anti-tumor effects of dendritic cells co-culturing with CIK cells

1 reference

12 December 2020

Propagation of large numbers of T cells with natural killer cell markers

1 reference

12 December 2020

Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma.

1 reference

12 December 2020

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

12 December 2020

Avidity dictates the lytic capacity of human cytolytic T lymphocyte clones with similar fine specificity against murine cells expressing HLA-B27 antigen

1 reference

12 December 2020

In vivo antitumor activity of anti-CD3-induced activated killer cells

1 reference

12 December 2020

A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma

1 reference

12 December 2020

Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells

1 reference

12 December 2020

Inhibition of human colon cancer growth by antibody-directed human LAK cells in SCID mice

1 reference

12 December 2020

Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer.

1 reference

12 December 2020

[Clinical observation on adoptive immunotherapy with autologous cytokine-induced killer cells for advanced malignant tumor]

1 reference

12 December 2020

10.1007/S00432-012-1179-1

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018